Alibaba, AUS Merchant Services Pay $600 Million to Settle US Drug-Sales Probe
Updated
Updated · Bloomberg · Jul 1
Alibaba, AUS Merchant Services Pay $600 Million to Settle US Drug-Sales Probe
1 articles · Updated · Bloomberg · Jul 1
Summary
$600 million will be paid by Alibaba and US payment processor AUS Merchant Services to resolve a federal investigation into illegal pharmaceutical and controlled-substance sales and imports.
The Justice Department said the companies entered a non-prosecution agreement on Wednesday, ending the case without criminal charges.
Prosecutors said the probe covered alleged failures between 2016 and 2024 to prevent violations of the Federal Food, Drug and Cosmetic Act.
The settlement puts a price on US scrutiny of how major e-commerce and payment platforms police cross-border sales of regulated drugs.